These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21598999)

  • 1. Improving in vivo hepatic transfection activity by controlling intracellular trafficking: the function of GALA and maltotriose.
    Akita H; Masuda T; Nishio T; Niikura K; Ijiro K; Harashima H
    Mol Pharm; 2011 Aug; 8(4):1436-42. PubMed ID: 21598999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Octaarginine- and pH sensitive fusogenic peptide-modified nanoparticles for liver gene delivery.
    Khalil IA; Hayashi Y; Mizuno R; Harashima H
    J Control Release; 2011 Dec; 156(3):374-80. PubMed ID: 21864599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional improvement of an IRQ-PEG-MEND for delivering genes to the lung.
    Ishitsuka T; Akita H; Harashima H
    J Control Release; 2011 Aug; 154(1):77-83. PubMed ID: 21619903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo.
    Hatakeyama H; Ito E; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
    J Control Release; 2009 Oct; 139(2):127-32. PubMed ID: 19540888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape.
    El-Sayed A; Masuda T; Khalil I; Akita H; Harashima H
    J Control Release; 2009 Sep; 138(2):160-7. PubMed ID: 19465073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multifunctional envelope-type nanodevice for use in nanomedicine: concept and applications.
    Nakamura T; Akita H; Yamada Y; Hatakeyama H; Harashima H
    Acc Chem Res; 2012 Jul; 45(7):1113-21. PubMed ID: 22324902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of lipid particles targeted via sugar-lipid conjugates as novel nuclear gene delivery system.
    Masuda T; Akita H; Nishio T; Niikura K; Kogure K; Ijiro K; Harashima H
    Biomaterials; 2008 Feb; 29(6):709-23. PubMed ID: 18001828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between a multifunctional envelope-type nano device and lipoplex for delivery to the liver.
    Yamauchi J; Hayashi Y; Kajimoto K; Akita H; Harashima H
    Biol Pharm Bull; 2010; 33(5):926-9. PubMed ID: 20460780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Methacryloyloxyethyl phosphorylcholine polymer (MPC)-coating improves the transfection activity of GALA-modified lipid nanoparticles by assisting the cellular uptake and intracellular dissociation of plasmid DNA in primary hepatocytes.
    Ukawa M; Akita H; Masuda T; Hayashi Y; Konno T; Ishihara K; Harashima H
    Biomaterials; 2010 Aug; 31(24):6355-62. PubMed ID: 20537380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional envelope-type nano device (MEND) as a non-viral gene delivery system.
    Kogure K; Akita H; Yamada Y; Harashima H
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):559-71. PubMed ID: 18037529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method.
    Kogure K; Moriguchi R; Sasaki K; Ueno M; Futaki S; Harashima H
    J Control Release; 2004 Aug; 98(2):317-23. PubMed ID: 15262422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of a fusiogenic peptide GALA for intracellular delivery.
    Nakase I; Kogure K; Harashima H; Futaki S
    Methods Mol Biol; 2011; 683():525-33. PubMed ID: 21053154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a multifunctional PEG-based gene delivery system containing nuclear localization signals and endosomal escape peptides.
    Moore NM; Sheppard CL; Sakiyama-Elbert SE
    Acta Biomater; 2009 Mar; 5(3):854-64. PubMed ID: 18926782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment of hepatocyte growth factor gene transfer mediated by octaarginine peptide-modified nanoparticles ameliorates LPS/D-galactosamine-induced hepatitis.
    Hayashi Y; Mizuno R; Ikramy KA; Akita H; Harashima H
    Nucleic Acid Ther; 2012 Oct; 22(5):360-3. PubMed ID: 22963044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique features of a pH-sensitive fusogenic peptide that improves the transfection efficiency of cationic liposomes.
    Futaki S; Masui Y; Nakase I; Sugiura Y; Nakamura T; Kogure K; Harashima H
    J Gene Med; 2005 Nov; 7(11):1450-8. PubMed ID: 16025556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo.
    Sato Y; Hatakeyama H; Sakurai Y; Hyodo M; Akita H; Harashima H
    J Control Release; 2012 Nov; 163(3):267-76. PubMed ID: 23000694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A touch-and-go lipid wrapping technique in microfluidic channels for rapid fabrication of multifunctional envelope-type gene delivery nanodevices.
    Kitazoe K; Wang J; Kaji N; Okamoto Y; Tokeshi M; Kogure K; Harashima H; Baba Y
    Lab Chip; 2011 Oct; 11(19):3256-62. PubMed ID: 21829858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Octaarginine-modified multifunctional envelope-type nano device for siRNA.
    Nakamura Y; Kogure K; Futaki S; Harashima H
    J Control Release; 2007 Jun; 119(3):360-7. PubMed ID: 17478000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient short interference RNA delivery to tumor cells using a combination of octaarginine, GALA and tumor-specific, cleavable polyethylene glycol system.
    Sakurai Y; Hatakeyama H; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
    Biol Pharm Bull; 2009 May; 32(5):928-32. PubMed ID: 19420766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronic acid controls the uptake pathway and intracellular trafficking of an octaarginine-modified gene vector in CD44 positive- and CD44 negative-cells.
    Yamada Y; Hashida M; Harashima H
    Biomaterials; 2015 Jun; 52():189-98. PubMed ID: 25818425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.